The APC induces numerous systemically available molecules (cytokines, chemokines), as well as NK, CD4+ and CD8+ cells and γδT-cells to form a complete tumor-specific immune arsenal which can be used against the malignant cells (Figure 20). This evidence concerns the gene CD8A and neoplasm.